Aktoudianakis; Evangelos
Patent Applications and Registrations
Patent applications and USPTO patent grants for Aktoudianakis; Evangelos.The latest application filed is for "toll like receptor modulator compounds".
- Aktoudianakis; Evangelos - Redwood City CA
- Aktoudianakis; Evangelos - Foster City CA
- Aktoudianakis; Evangelos - San Mateo CA
| Patent | Date |
|---|---|
| Substituted eneoxindoles and uses thereof Grant 11,453,681 - Aktoudianakis , et al. September 27, 2 | 2022-09-27 |
| Toll Like Receptor Modulator Compounds App 20220218709 - Aktoudianakis; Evangelos ; et al. | 2022-07-14 |
| Pd-1/pd-l1 Inhibitors App 20210323922 - Aktoudianakis; Evangelos ; et al. | 2021-10-21 |
| Pd-1/pd-l1 Inhibitors App 20210053946 - Aktoudianakis; Evangelos ; et al. | 2021-02-25 |
| Pd-1/pd-l1 Inhibitors App 20210024494 - Aktoudianakis; Evangelos ; et al. | 2021-01-28 |
| PD-1/PD-L1 inhibitors Grant 10,899,735 - Aktoudianakis , et al. January 26, 2 | 2021-01-26 |
| Processes For Preparing Toll-like Receptor Modulator Compounds App 20210017170 - Aktoudianakis; Evangelos ; et al. | 2021-01-21 |
| Substituted Eneoxindoles And Uses Thereof App 20200392153 - Aktoudianakis; Evangelos ; et al. | 2020-12-17 |
| PD-1/PD-L1 inhibitors Grant 10,774,071 - Aktoudianakis , et al. September 15, 2 | 2020-09-15 |
| PD-1/PD-L1 inhibitors Grant 10,710,986 - Aktoudianakis , et al. | 2020-07-14 |
| Pd-1/pd-l1 Inhibitors App 20200017471 - Aktoudianakis; Evangelos ; et al. | 2020-01-16 |
| Pd-1/pd-l1 Inhibitors App 20190345131 - AKTOUDIANAKIS; Evangelos ; et al. | 2019-11-14 |
| Compounds for the treatment of hepatitis B virus infection Grant 10,442,804 - Aktoudianakis , et al. Oc | 2019-10-15 |
| Toll Like Receptor Modulator Compounds App 20190282576 - Aktoudianakis; Evangelos ; et al. | 2019-09-19 |
| Pd-1/pd-l1 Inhibitors App 20190270727 - Aktoudianakis; Evangelos ; et al. | 2019-09-05 |
| Toll like receptor modulator compounds Grant 10,285,990 - Aktoudianakis , et al. | 2019-05-14 |
| Pd-1/pd-l1 Inhibitors App 20180305315 - Aktoudianakis; Evangelos ; et al. | 2018-10-25 |
| Benzimidazole Derivatives As Bromodomain Inhibitors App 20180282316 - Aktoudianakis; Evangelos ; et al. | 2018-10-04 |
| Compounds For The Treatment Of Hepatitis B Virus Infection App 20180251460 - Aktoudianakis; Evangelos ; et al. | 2018-09-06 |
| Compounds For The Treatment Of Hepatitis B Virus Infection App 20170342068 - Aktoudianakis; Evangelos ; et al. | 2017-11-30 |
| Toll Like Receptor Modulator Compounds App 20170281627 - Aktoudianakis; Evangelos ; et al. | 2017-10-05 |
| Toll like receptor modulator compounds Grant 9,670,205 - Aktoudianakis , et al. June 6, 2 | 2017-06-06 |
| Benzimidazole Derivatives As Bromodomain Inhibitors App 20160376261 - Aktoudianakis; Evangelos ; et al. | 2016-12-29 |
| Toll Like Receptor Modulator Compounds App 20160289229 - Aktoudianakis; Evangelos ; et al. | 2016-10-06 |
| Benzimidazole derivatives as bromodomain inhibitors Grant 9,458,145 - Aktoudianakis , et al. October 4, 2 | 2016-10-04 |
| Benzimidazole Derivatives As Bromodomain Inhibitors App 20160075695 - Aktoudianakis; Evangelos ; et al. | 2016-03-17 |
| Benzimidazolone derivatives as bromodomain inhibitors Grant 9,255,089 - Aktoudianakis , et al. February 9, 2 | 2016-02-09 |
| Benzimidazolone Derivatives As Bromodomain Inhibitors App 20160031868 - Aktoudianakis; Evangelos ; et al. | 2016-02-04 |
| Benzimidazole Derivatives As Bromodomain Inhibitors App 20140336190 - Aktoudianakis; Evangelos ; et al. | 2014-11-13 |
| Benzimidazolone Derivatives As Bromodomain Inhibitors App 20140296246 - Aktoudianakis; Evangelos ; et al. | 2014-10-02 |
| Antiviral compounds Grant 7,998,950 - Aktoudianakis , et al. August 16, 2 | 2011-08-16 |
| Antiviral Compounds App 20100022508 - Aktoudianakis; Evangelos ; et al. | 2010-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 